Clinical Trials on Hereditary Breast and Ovarian Cancer in United Kingdom
Total 24021 results
-
National Health Service, United KingdomSouthern Health and Social Care TrustCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBRCA1 Syndrome | BRCA2 Syndrome | No Evidence of Disease | Hereditary Ovarian Carcinoma | Hereditary Female Breast CarcinomaUnited States
-
Royal Surrey County Hospital NHS Foundation TrustRecruitingFallopian Tube Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Ovarian Neoplasm | Ovarian Neoplasm EpithelialUnited Kingdom
-
University of ManchesterManchester University NHS Foundation TrustCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Endometrial Carcinoma | Stage III Bladder Cancer | Cervical Squamous Cell Carcinoma | Stage IV Breast Cancer | Malignant Uterine Neoplasm | Recurrent Bladder Carcinoma | Recurrent... and other conditionsUnited States
-
Merrimack PharmaceuticalsSanofiCompletedLocally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, | Primary Peritoneal Cancer or Endometrial Cancer | Locally Advanced/Metastatic Her2 Non Overexpressing Breast CancerUnited States
-
ExcellaBio LLCTerminatedGastric Cancer | Ovarian Cancer | Breast Cancer FemaleUnited States
-
Imperial College LondonCancer Research UKCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerUnited Kingdom
-
Imperial College London4D pharma plcActive, not recruitingMelanoma | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Renal Cancer | Urethral Cancer | Uterine CancerUnited Kingdom
-
Tango Therapeutics, Inc.RecruitingBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityWithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Stage III Fallopian Tube Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage III Primary Peritoneal Cancer AJCC v8 | Stage IV Fallopian Tube Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IV Primary... and other conditionsUnited States
-
University of WashingtonGlaxoSmithKlineRecruitingAnatomic Stage III Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Pancreatic Carcinoma | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Unresectable Pancreatic... and other conditionsUnited States
-
VelosBio Inc.CompletedGastric Cancer | Pancreatic Cancer | NSCLC | Platinum-resistant Ovarian Cancer | Triple-negative Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Non-squamous Non-small-cell Lung Cancer | Estrogen-receptor-positive Breast Cancer | Progesterone-receptor-positive Breast Cancer | Estrogen-receptor-negative... and other conditionsUnited States, Canada
-
Imperial College Healthcare NHS TrustImperial College LondonTerminatedBreast Cancer | Breast DiseaseUnited Kingdom
-
Zedsen LimitedImperial College Healthcare NHS TrustRecruitingBreast Cancer | Benign Breast DiseaseUnited Kingdom
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; Cancer Research UK; Astex Pharmaceuticals, Inc.RecruitingCervical Cancer | Triple Negative Breast Cancer | Advanced CancerUnited Kingdom
-
Imperial College LondonCompletedToxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.United Kingdom
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownOvarian Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia and other collaboratorsCompletedMetastatic Breast CancerSpain, United Kingdom
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Ovarian Cancer | Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterPfizer; Acrotech Biopharma Inc.RecruitingMetastatic Breast Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Ovarian CarcinomaUnited States
-
Leap Therapeutics, Inc.Pfizer; Merck KGaA, Darmstadt, GermanyTerminatedSolid Tumors | Advanced Triple Negative Breast Cancer | Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer | Advanced Metastatic Castration-Resistant Prostate Cancer | Advanced Platinum-Resistant Ovarian CancerUnited States
-
Royal Marsden NHS Foundation TrustRecruitingBreast Cancer | LymphedemaUnited Kingdom
-
University of LeedsBreast Cancer NowCompletedMetastatic Breast CancerUnited Kingdom
-
University College, LondonBarts & The London NHS Trust; Anticancer Fund, Belgium; JP Moulton Charitable...RecruitingOvarian Cancer | Fallopian Tube Cancer | Relapsed Ovarian Cancer | Peritoneal Cancer | High Grade Serous Carcinoma | Ovary Cancer | Endometrioid CarcinomaUnited Kingdom
-
National Cancer Institute (NCI)CompletedBreast Cancer | Ovarian CancerUnited States
-
PfizerCompletedBreast Cancer MetastaticArgentina, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Endometrial Carcinoma | Male Breast Cancer | Recurrent Small Cell Lung Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Gastric Cancer | Recurrent Non-small Cell Lung CancerUnited States
-
University of OxfordoxBRC; Vodafone UK Foundation; Centre for Statistics in Medicine; Oncology Clinical...CompletedMetastatic Colorectal Cancer | Metastatic Breast CancerUnited Kingdom
-
Medical Research CouncilCompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLynch Syndrome | Hereditary Breast Carcinoma | Hereditary Ovarian CarcinomaUnited States
-
Imperial College LondonGlaxoSmithKlineCompletedOvarian NeoplasmUnited Kingdom
-
St George's, University of LondonUnknownBreast Cancer | Fatigue | Cancer Survivor | Psychosocial Effects of Cancer and Its TreatmentUnited Kingdom
-
University of AberdeenNHS GrampianUnknownMalignant Breast Tissue NeoplasmUnited Kingdom
-
Cancer Research UKActive, not recruitinga. Colorectal Cancer | b. High Grade Serous Ovarian Cancer | c. Non Small-cell Lung Cancer (Squamous Cell Variant) | d. Squamous Carcinoma of the Oesophagus | e. Squamous Carcinoma of the Head and Neck (HPV Negative) | f. Urothelial Cancer | g. Breast Cancer (Triple Negative Type) | h. Pancreatic...United Kingdom
-
National Cancer Institute (NCI)CompletedAdvanced Breast Cancer | Advanced Solid Tumors | Primary Peritoneal Cancer | Advanced Ovarian CancerUnited States
-
Manchester University NHS Foundation TrustCompletedBreast CancerUnited Kingdom
-
University of OxfordBlue Earth DiagnosticsCompleted
-
NHS TaysideUniversity of DundeeCompleted
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom
-
NHS Greater Glasgow and ClydeCanniesburn Research TrustUnknownBreast CancerUnited Kingdom
-
Royal Surrey County Hospital NHS Foundation TrustUniversity of Surrey; Target Ovarian CancerUnknownPeritoneal Diseases | Ovarian Neoplasms | Peritoneal Neoplasms | Ovarian Cancer | Abdominal Neoplasm | Bowel Obstruction | Primary Peritoneal Carcinoma | Metastatic Ovarian Cancer | Ovarian DiseaseUnited Kingdom
-
National Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Triple-Negative Breast Cancer | Serous Carcinoma CancerUnited States, Canada
-
King's College Hospital NHS TrustRecruitingBreast CancerUnited Kingdom
-
Lightpoint Medical LimitedNot yet recruiting
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompleted
-
Imperial College LondonTerminatedBreast CancerUnited Kingdom
-
University of StirlingOxford Brookes University; University of BathWithdrawn
-
Royal Marsden NHS Foundation TrustUnknownBreast CancerUnited Kingdom